ResearcherZhongshan People's HospitalActive in the last 2 years

Fengyun Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2266-066X; OpenAlex author ID A5028775467. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Letrozole-Based Near-Infrared Dynamic Imaging Targeting Ductal-Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/adhm.202402913 ↗
SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro. Co-author DOI 10.1007/s11033-022-07504-z ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaodong Ma · 2 shared papers, 2022–2024 · strength 0.35
- Paper Letrozole-Based Near-Infrared Dynamic Imaging Targeting Ductal-Vascular RhoJ From Pancreatic Intraepithelial Neoplasia … DOI 10.1002/adhm.202402913 ↗
- Paper SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemothe… DOI 10.1007/s11033-022-07504-z ↗
Zhi Cao · 1 shared paper, 2024 · strength 0.18
- Paper Letrozole-Based Near-Infrared Dynamic Imaging Targeting Ductal-Vascular RhoJ From Pancreatic Intraepithelial Neoplasia … DOI 10.1002/adhm.202402913 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.